创伤后胰腺切除术后早期胰腺功能障碍:一级创伤中心18年报告
该研究回顾1996至2013年一级创伤中心331例胰腺损伤患者,109例(33%)行胰腺切除,84例存活出院,排除4例后分析80例。73例(91%)行远端胰腺切除,7例(9%)行近端胰腺切除,无全胰切除。远端切除组52%术后需胰岛素,其中47%需胰岛素≤1天,无人出院带胰岛素;近端切除组7例中6例术后需胰岛素,2例出院时仍依赖胰岛素。两组均无外分泌功能障碍证据,出院时均未接受胰腺酶补充。
要点
- 创伤后远端胰腺切除80例中73例(91%),近端切除7例(9%),无全胰切除,分析人群为伤前无糖尿病且存活出院者。
- 远端切除组术后52%需胰岛素,其中47%需胰岛素≤1天,无患者出院时带胰岛素。
- 近端切除组7例中6例术后需胰岛素,2例出院时仍依赖胰岛素。
- 远端与近端切除组出院时均无外分泌功能障碍证据,均未接受胰腺酶补充。
- 作者结论认为创伤后远端或近端胰腺切除术后外分泌功能障碍罕见,远端切除术后早期内分泌功能障碍也罕见,但近端切除术后可见。
适用人群与场景
- 1996至2013年一级创伤中心收治的胰腺损伤患者,排除伤前糖尿病患者,纳入存活出院者。
- 按解剖切除范围分为远端胰腺切除、近端胰腺切除或全胰切除三组;实际分析80例中远端切除73例、近端切除7例、全胰切除0例。
诊断标准与关键阈值
- 内分泌胰腺功能评估采用血糖水平、糖化血红蛋白和胰岛素需求量。
- 外分泌胰腺功能评估采用报告的脂肪泻、腹泻或需要补充胰腺酶。
研究设计与关键结果
- 研究类型为单中心18年治疗性研究(证据等级IV级),331例胰腺损伤中109例(33%)需切除,84例存活出院,排除4例后分析80例。
- 远端切除组73例(91%),以男性为主(88%),中位年龄24岁,平均BMI 27(kg/m);38例(52%)术后需胰岛素,其中47%需胰岛素≤1天,无患者出院时带胰岛素。
- 近端切除组7例(9%),以男性为主(86%),中位年龄31岁,平均BMI 32(kg/m);7例中6例术后需胰岛素,7例中2例出院时仍依赖胰岛素。
- 远端与近端切除组均无外分泌功能障碍证据,出院时均未接受胰腺酶补充。
证据类型、等级与局限
- 证据类型:治疗性研究,证据等级IV级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为创伤后远端或近端胰腺切除术后外分泌功能障碍罕见。
- 作者结论认为创伤后远端胰腺切除术后早期内分泌功能障碍罕见,但近端切除术后可见。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Early pancreatic dysfunction after resection in trauma has not been well characterized. The objective of this study was to examine the incidence and clinical impact of new-onset endocrine and exocrine dysfunction after pancreatic resection for trauma.
METHODS: All patients sustaining a pancreatic injury from 1996 to 2013 were identified. Patients with preinjury diabetes were excluded. Survivors were divided into three groups according to the extent of anatomic resection-distal, proximal, or total pancreatectomy. Clinical demographics and outcome data were abstracted. Blood glucose levels, hemoglobin A1c, and insulin requirements were used to assess endocrine pancreatic function. Reported steatorrhea, diarrhea, or supplemental pancreatic enzyme requirements were used to assess exocrine pancreatic function.
RESULTS: During the study period, 331 pancreatic injuries were identified, of which 109 (33%) required resection and 84 survived to hospital discharge. Four were excluded. Of 80 cases analyzed, 73 (91%) underwent distal pancreatectomy, 7 (9%) proximal pancreatectomy, and none a total pancreatectomy. The distal resection group was predominantly male (88%), median age 24 years, and mean BMI 27 (kg/m). Thirty-eight (52%) required insulin postoperatively, with the greatest proportion (47%) requiring insulin for ≤1 day; no patients were discharged on insulin. The proximal resection group was predominantly male (86%), median age 31 years, and mean BMI 32 (kg/m). Six of seven required insulin postoperatively and two of seven were insulin dependent at time of hospital discharge. For both distal and proximal resections, none had evidence of exocrine dysfunction or received pancreatic enzyme supplementation at discharge.
CONCLUSION: Exocrine dysfunction after distal or proximal pancreatectomy for trauma is rare. The incidence of early onset endocrine dysfunction after traumatic distal pancreatectomy is also rare; however, it can be seen after proximal resection.
LEVEL OF EVIDENCE: Therapeutic study, level IV.
参考来源
- Mansfield N, Inaba K, Berg R, et al. Early pancreatic dysfunction after resection in trauma: An 18-year report from a Level I trauma center. J Trauma Acute Care Surg. 2017. PMID: 28225740. doi:10.1097/TA.0000000000001327
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。